TELOMERE SHORTENING
Clinical trials for TELOMERE SHORTENING explained in plain language.
Never miss a new study
Get alerted when new TELOMERE SHORTENING trials appear
Sign up with your email to follow new studies for TELOMERE SHORTENING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare bone marrow failure: experimental drug EXG34217 enters human testing
Disease control OngoingThis early-stage study tests a new drug called EXG34217 in 12 people aged 12 and older who have bone marrow failure due to telomere biology disorders. The main goal is to check if the drug is safe and tolerable. Researchers will also look for improvements in blood cell counts and…
Matched conditions: TELOMERE SHORTENING
Phase: PHASE1 • Sponsor: Elixirgen Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
Exercise and nutrition may keep cells young in elderly women
Knowledge-focused OngoingThis study looks at how nutritional counseling and physical exercise affect aging markers in elderly women. Researchers will measure telomere length and other signs of cellular aging in 80 women aged 60-75, some with obesity and some without. The goal is to see if lifestyle chang…
Matched conditions: TELOMERE SHORTENING
Phase: NA • Sponsor: University of Sao Paulo • Aim: Knowledge-focused
Last updated May 26, 2026 04:55 UTC